300326.SHE Shanghai Kinetic Medical Co
- Market cap
- CNY 4.56B
- P/E
- 17.2x
- P/B
- 1.54x
- ROE
- 9.2%
- Dividend yield
- 0.10%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 300326.SHE undervalued?
Graham number300326.SHE trades 8.4% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Shanghai Kinetic Medical Co fundamental analysis
No fundamental analysis for Shanghai Kinetic Medical Co yet.
Shanghai Kinetic Medical Co stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Shanghai Kinetic Medical Co
Shanghai Kinetic Medical Co., Ltd, together with its subsidiaries, engages in the research, development, manufacturing, and sale of medical devices in China and internationally. The company offers invasive spinal, invasive vertebroplasty, radiofrequency ablation, orthopedic trauma implant equipment, artificial organs, orthopedic surgical instruments, and other medical products, as well as surgical energy platforms and consumables. It is also involved in the provision of clea…
Full company profileShanghai Kinetic Medical Co financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Shanghai Kinetic Medical Co annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 551M | 802M | 931M | 1.22B | 1.06B | 1.27B | 1.17B | 956M | 985M | 963M | 745M |
| Gross Profit | 415M | 501M | 559M | 802M | 704M | 778M | 740M | 490M | 479M | 518M | 511M |
| Operating Income | 180M | 232M | 498M | 359M | -87.2M | 219M | 97.7K | 140M | -107M | 112M | 195M |
| EBITDA | 235M | 280M | 555M | 418M | -31.8M | 296M | 72.8M | 206M | -51.4M | 221M | 275M |
| Net Income | 159M | 195M | 463M | 302M | -127M | 162M | -21.3M | 113M | -106M | 135M | 274M |
| EPS | 0.23 | 0.27 | 0.64 | 0.42 | -0.18 | 0.22 | -0.03 | 0.16 | -0.15 | 0.19 | 0.38 |
| Balance Sheet | |||||||||||
| Total Assets | 2.22B | 2.69B | 3.57B | 3.77B | 3.68B | 3.51B | 3.41B | 3.35B | 3.35B | 3.07B | 3.17B |
| Total Liabilities | 376M | 653M | 1.07B | 1.02B | 993M | 731M | 597M | 405M | 532M | 181M | 169M |
| Shareholders' Equity | 1.84B | 2.03B | 2.50B | 2.75B | 2.64B | 2.73B | 2.74B | 2.86B | 2.72B | 2.86B | 2.97B |
| Cash & Short-term Investments | 465M | 327M | 1.05B | 926M | 866M | 907M | 972M | 1.04B | 1.22B | 288M | 436M |
| Total Debt | 268M | 347M | 696M | 596M | 639M | 416M | 321M | 173M | 297M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 130M | 147M | 95.3M | 256M | 285M | 378M | 237M | 274M | 158M | 189M | - |
| Capital Expenditure | 38.9M | 39.0M | 37.8M | 40.3M | 29.6M | 49.2M | 41.5M | 53.8M | 82.8M | 66.2M | 16.6M |
| Free Cash Flow | 91.5M | 108M | 57.5M | 215M | 255M | 329M | 195M | 220M | 74.9M | 123M | 192M |
| Ratios | |||||||||||
| ROE | 8.6% | 9.6% | 18.5% | 11.0% | -4.8% | 5.9% | -0.8% | 3.9% | -3.9% | 4.7% | 9.2% |
| ROA | 7.2% | 7.2% | 13.0% | 8.0% | -3.4% | 4.6% | -0.6% | 3.4% | -3.2% | 4.4% | 8.6% |
| Net Profit Margin | 28.8% | 24.3% | 49.7% | 24.7% | -11.9% | 12.8% | -1.8% | 11.8% | -10.7% | 14.0% | 36.7% |
| Debt to Equity | 0.15x | 0.17x | 0.28x | 0.22x | 0.24x | 0.15x | 0.12x | 0.06x | 0.11x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Shanghai Kinetic Medical Co dividends
- Dividend yield
- 0.10%
- Forward dividend
- 0.10 CNY
- Payout ratio
- 3.4%
- Ex-dividend date
- Jun 24, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 4.60M | 0.01 | 3.4% |
| 2024 | CNY 46.1M | 0.06 | - |
| 2023 | CNY 5.11M | 0.01 | 4.5% |
| 2022 | CNY 35.5M | 0.05 | - |
| 2021 | CNY 35.9M | 0.05 | 22.2% |
| 2020 | CNY 56.1M | 0.08 | - |
| 2019 | CNY 50.6M | 0.07 | 16.7% |
| 2018 | CNY 42.2M | 0.06 | 9.1% |
| 2017 | CNY 33.2M | 0.05 | 17.0% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 17.93912:10 on Oct 21, 2016.
Who owns Shanghai Kinetic Medical Co
- Insiders 28.80%
- Institutions 0.00%
- Public & others 71.20%
- Shares outstanding 717M
- Free float 548M
Shanghai Kinetic Medical Co company profile
- Company name
- Shanghai Kinetic Medical Co
- Ticker
- 300326.SHE
- ISIN
- CNE100001FG9
- Exchange
- Shenzhen Stock Exchange
- Listed since
- Jun 13, 2012
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 553
- Fiscal year end
- December
- Address
- Building 23, Shanghai, China, 201201
- Phone
- 86 21 5072 0586
- Website
- kineticmedinc.com.cn
About Shanghai Kinetic Medical Co
Shanghai Kinetic Medical Co., Ltd, together with its subsidiaries, engages in the research, development, manufacturing, and sale of medical devices in China and internationally. The company offers invasive spinal, invasive vertebroplasty, radiofrequency ablation, orthopedic trauma implant equipment, artificial organs, orthopedic surgical instruments, and other medical products, as well as surgical energy platforms and consumables. It is also involved in the provision of cleaning and sterilization solutions for medical devices, equipment, and medical and health materials and supplies; medical disinfection services; trading medical devices; technical consultation; after-sales technical services; and production and sale of teaching aids. The company exports its products. Shanghai Kinetic Medical Co., Ltd was founded in 2005 and is headquartered in Shanghai, China.
Shanghai Kinetic Medical Co management
5- Mr. Kui DingGeneral Manager · born 1982
- Mr. Yuanping Li CPACFO & Accounting Supervisor · born 1979
- Ms. Qing LiuBoard Secretary · born 1976
- Mr. Jinyu ZhangDeputy General Manager · born 1968
- Mr. Wei LiuDeputy General Manager · born 1974